BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9368408)

  • 21. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
    Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromoblastomycosis.
    Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
    Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fonsecaea pedrosoi-induced chromoblastomycosis: about a case].
    Baline K; Hali F
    Pan Afr Med J; 2018; 30():187. PubMed ID: 30455816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromoblastomycosis in Kerala, India.
    Chandran V; Sadanandan SM; Sobhanakumari K
    Indian J Dermatol Venereol Leprol; 2012; 78(6):728-33. PubMed ID: 23075642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromoblastomycosis in India: Review of 169 cases.
    Agarwal R; Singh G; Ghosh A; Verma KK; Pandey M; Xess I
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005534. PubMed ID: 28771470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the fungal cell wall in the granulomatous response of mice to the agents of chromomycosis.
    Silva CL; Fazioli RA
    J Med Microbiol; 1985 Dec; 20(3):299-305. PubMed ID: 4068024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taxonomic criteria for the fungi of chromoblastomycosis with reference to Fonsecaea pedrosoi.
    Carrión AL; Silva-Hutner M
    Int J Dermatol; 1971; 10(1):35-43. PubMed ID: 5900177
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous Chromoblastomycosis Mimicking Tuberculosis Verrucosa Cutis: Look for Copper Pennies!
    Bandyopadhyay A; Majumdar K; Gangopadhyay M; Banerjee S
    Turk Patoloji Derg; 2015; 31(3):223-5. PubMed ID: 24272932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of extracellular enzymes from chromoblastomycosis agents reveals the potential association of phospholipase with the severity of the lesions.
    Montoya AM; Montesino CA; Carrión-Álvarez D; González GM; Rojas OC
    Microb Pathog; 2020 Oct; 147():104367. PubMed ID: 32649963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Generalized chromomycosis caused by Phialophora verrucosa].
    Radouane N; Hali F; Khadir K; Soussi M; Ouakadi A; Marouane S; Zamiati S; Benchikhi H
    Ann Dermatol Venereol; 2013 Mar; 140(3):197-201. PubMed ID: 23466152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromoblastomycosis due to Fonsecaea pedrosoi: an old wine in a rare bottle.
    Khan S; Kumar A; Vinod V; Prabhakar V; Eapen M; Thomas J; Dinesh K; Karim S
    J Infect Dev Ctries; 2015 Mar; 9(3):325-9. PubMed ID: 25771474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical treatment of corneal infection due to Fonsecaea pedrosoi--case report.
    Höfling-Lima AL; Guarro J; Freitas Dd; Godoy P; Gené J; Souza LB; Zaror L; Romano AC
    Arq Bras Oftalmol; 2005; 68(2):270-2. PubMed ID: 15905955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
    Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
    PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of chromomycosis with a combination of 5-fluorocytosine and thiabendazole. Apropos of a Zairian case due to Fonsecaea pedrosoi].
    De Clercq D; Kakiesse M; De Vroey C; Mazebo P
    Ann Soc Belg Med Trop; 1985; 65(1):95-7. PubMed ID: 4004379
    [No Abstract]   [Full Text] [Related]  

  • 35. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
    Gupta AK; Taborda PR; Sanzovo AD
    Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulse itraconazole 400 mg daily in the treatment of chromoblastomycosis.
    Ungpakorn R; Reangchainam S
    Clin Exp Dermatol; 2006 Mar; 31(2):245-7. PubMed ID: 16487103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fonsecaea pedrosoi cerebral phaeohyphomycosis ("chromoblastomycosis"): first human culture-proven case reported in Brazil.
    Nóbrega JP; Rosemberg S; Adami AM; Heins-Vaccari EM; Lacaz Cda S; de Brito T
    Rev Inst Med Trop Sao Paulo; 2003; 45(4):217-20. PubMed ID: 14502350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
    Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
    Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chromoblastomycosis in Gabon. Study of 64 cases].
    Kombila M; Gomez de Diaz M; Richard-Lenoble D; Renders A; Walter P; Billiault X; Joire A; Coniquet-Folquet S; Duong TH; de Bièvre C
    Sante; 1995; 5(4):235-44. PubMed ID: 7582644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the conidial development and cleistothecium-like structure of some strains of Fonsecaea pedrosoi. Comparison with other close Dematiaeae.
    Ibrahim-Granet O; de Bièvre C
    Mycopathologia; 1984 Feb; 84(2-3):181-6. PubMed ID: 6538933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.